3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
16
Completed
15
Recruiting
3
Terminated
2
Withdrawn
1
Active not recruiting
1
Sponsor Class
OTHER
124
INDUSTRY
99
NIH
21
NETWORK
3
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Breast Neoplasms
10
Stomach Neoplasms
8
Prostatic Neoplasms
6
Ovarian Neoplasms
5
Neoplasms
4
Lung Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Endometrial Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Lymphoma, Follicular
2
Fallopian Tube Neoplasms
2
COVID-19
2
Breast Cancer Lymphedema
2
Anxiety Disorders
2
Adenoma
2
Uveitis
1
Uterine Cervical Dysplasia
1
Stress, Psychological
1
Stomatitis
1
Skin Neoplasms
1
Scleritis
1
Renal Insufficiency, Chronic
1
Radiation Injuries
1
Pulmonary Disease, Chronic Obstructive
1
Progression-Free Survival
1
Ovarian, Fallopian, and Primary Peritoneal Cancer
1
Operable Breast Cancer
1
Interventions
tremelimumab
1
durvalumab
1
Radiation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
OTHER_GOV
×
Neoplasm Metastasis
×
Clear all
NCT05000710
2024-12-05
CORAL-Lung
Sheba Medical Center
Phase 2
Active not recruiting
29 enrolled